polytrimethylene carbonate has been researched along with sirolimus in 2 studies
Studies (polytrimethylene carbonate) | Trials (polytrimethylene carbonate) | Recent Studies (post-2010) (polytrimethylene carbonate) | Studies (sirolimus) | Trials (sirolimus) | Recent Studies (post-2010) (sirolimus) |
---|---|---|---|---|---|
146 | 3 | 77 | 20,711 | 2,368 | 11,516 |
Protein | Taxonomy | polytrimethylene carbonate (IC50) | sirolimus (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.25 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 2 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 2 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Mus musculus (house mouse) | 0.001 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0897 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.0042 | |
Regulatory-associated protein of mTOR | Homo sapiens (human) | 0.225 | |
Target of rapamycin complex subunit LST8 | Homo sapiens (human) | 0.225 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 1.9 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dobrzynski, P; Jarzabek, B; Jelonek, K; Kasperczyk, J; Li, S | 1 |
Hong, D; Li, H; Liu, J; Tan, L; Xia, Y; Xu, K; Yang, K; Zhang, B; Zheng, F; Zhong, H | 1 |
2 other study(ies) available for polytrimethylene carbonate and sirolimus
Article | Year |
---|---|
Controlled poly(l-lactide-co-trimethylene carbonate) delivery system of cyclosporine A and rapamycine--the effect of copolymer chain microstructure on drug release rate.
Topics: Cyclosporine; Delayed-Action Preparations; Dioxanes; Drug Carriers; Drug Compounding; Drug Delivery Systems; Immunosuppressive Agents; Polyesters; Polymers; Sirolimus; Solubility | 2011 |
Enhanced efficacy of sirolimus-eluting bioabsorbable magnesium alloy stents in the prevention of restenosis.
Topics: Alloys; Angioplasty; Animals; Aorta, Abdominal; Aortic Diseases; Arterial Occlusive Diseases; Cardiovascular Agents; Cell Proliferation; Coated Materials, Biocompatible; Constriction, Pathologic; Dioxanes; Disease Models, Animal; Drug-Eluting Stents; Endothelial Cells; Hyperplasia; Lactic Acid; Magnesium; Male; Polyesters; Polymers; Prosthesis Design; Rabbits; Secondary Prevention; Sirolimus; Time Factors; Wound Healing | 2011 |